How does ulcerative colitis increase the risk of anemia. What are the common symptoms of anemia in UC patients. Which treatment options are available for managing anemia in ulcerative colitis. How can proper UC management help prevent anemia complications.

The Link Between Ulcerative Colitis and Anemia: Unraveling the Connection

Ulcerative colitis (UC), a form of inflammatory bowel disease characterized by inflammation in the large intestine, significantly increases the risk of developing anemia. Approximately one-third of individuals living with UC also experience anemia, a condition marked by lower levels of red blood cells and hemoglobin in the blood. This correlation stems from various factors associated with UC, including reduced iron absorption, diminished absorption of essential vitamins and minerals, and blood loss due to intestinal inflammation.

Understanding the relationship between UC and anemia is crucial for effective management of both conditions. The intestinal inflammation caused by UC can impair the body’s ability to absorb iron properly, leading to iron deficiency anemia. Additionally, chronic intestinal bleeding, a common symptom of UC, can result in substantial blood loss, further contributing to anemia development.

Key Factors Contributing to Anemia in UC Patients

• Impaired iron absorption due to intestinal inflammation
• Chronic blood loss from intestinal bleeding
• Reduced absorption of vital nutrients like vitamin B12 and folic acid
• Potential side effects of certain UC medications

Given the prevalence of anemia in UC patients, regular screening for anemia is essential, even in the absence of obvious symptoms. Early detection and appropriate management can significantly improve the quality of life for individuals dealing with both UC and anemia.

Recognizing the Symptoms: Anemia’s Impact on UC Patients

Anemia can manifest in various ways, and not all individuals will experience the same symptoms. However, being aware of potential indicators can help UC patients seek timely medical attention. Common symptoms of anemia in UC patients include:

• Persistent headaches
• Diminished appetite
• Cognitive difficulties, including trouble concentrating
• Increased irritability
• Overwhelming fatigue
• Tingling or numbness in hands and feet
• Cold extremities

As anemia progresses, additional symptoms may emerge, such as:

• Irregular menstrual bleeding
• Mouth ulcers
• Bluish tint in the whites of the eyes
• Brittle nails
• Frequent lightheadedness
• Reduced libido in males
• Inflamed or sore tongue
• Shortness of breath, even during mild exertion

Recognizing these symptoms and promptly reporting them to a healthcare provider can lead to earlier diagnosis and more effective management of anemia in UC patients.

Diagnostic Approaches: Identifying Anemia in UC Patients

Diagnosing anemia in individuals with ulcerative colitis involves a comprehensive approach, utilizing various tests and physical examinations. Healthcare providers typically employ the following diagnostic methods:

Blood Tests

A series of blood tests are crucial in identifying anemia and its underlying causes:

• Complete blood count (CBC): Assesses the levels of red blood cells and hemoglobin
• Vitamin B12 level test: Determines if there’s a deficiency in this essential vitamin
• Iron level tests: Measures serum iron, ferritin, and total iron-binding capacity
• Folic acid level test: Checks for potential folate deficiency
• Reticulocyte count: Evaluates the number of immature red blood cells in the blood

Physical Examination

During a physical exam, healthcare providers look for signs that may indicate anemia, such as:

• Rapid heart rate
• Pale skin tone
• Slight fever
• Presence of a heart murmur
• Low blood pressure, particularly when standing up

Is a specialized endoscopic procedure necessary for diagnosing anemia in UC patients? While endoscopic procedures are essential for monitoring UC progression, they are not typically required for anemia diagnosis. Blood tests and physical examinations are usually sufficient for identifying anemia in individuals with ulcerative colitis.

Treatment Strategies: Managing Anemia in Ulcerative Colitis Patients

Treating anemia in UC patients requires a tailored approach based on various factors, including the severity of anemia, the current state of UC, and the presence of other medical conditions. Healthcare providers consider the following aspects when developing a treatment plan:

• Whether UC is in an active state or remission
• The presence of other medical issues
• Existence of additional nutritional deficiencies

Common treatment options for anemia in UC patients include:

Iron Supplementation

Iron supplements are a primary treatment for iron-deficiency anemia in UC patients. The method of administration depends on the individual’s condition:

• Oral supplements: Suitable for patients with UC in remission
• Intravenous (IV) iron infusions: Preferred for patients with active UC or those who cannot tolerate oral supplements

Can dietary changes alone resolve anemia in UC patients? While incorporating iron-rich foods into the diet can be beneficial for patients in remission, dietary changes alone are often insufficient to treat anemia in UC patients. Medical interventions, such as iron supplementation, are typically necessary for effective management.

Other Nutritional Supplements

To address reduced absorption of essential nutrients, healthcare providers may prescribe additional supplements, including:

• Vitamin B12 supplements
• Folic acid supplements

Blood Transfusions

In cases of severe anemia, blood transfusions may be necessary. This procedure involves:

1. Blood type testing to ensure compatibility
2. Insertion of an IV line to deliver healthy blood
3. A transfusion process lasting 1-4 hours

Blood transfusions help increase hemoglobin and oxygen levels in the blood, providing rapid relief for severe anemia symptoms.

Holistic Management: Addressing UC to Alleviate Anemia

Effectively managing ulcerative colitis is crucial in treating and preventing anemia. While there is no cure for UC, a comprehensive treatment approach can help control the disease and reduce the risk of anemia-related complications. Key components of UC management include:

Medications

Various medications can help manage UC symptoms and reduce inflammation:

• Aminosalicylates
• Corticosteroids
• Immunomodulators
• Targeted synthetic small molecules
• Biologics

These medications aim to limit flare-ups and minimize intestinal inflammation, which can help prevent anemia development.

Dietary Management

Working with a healthcare provider or registered dietitian to develop an appropriate diet plan can help manage UC symptoms and potentially reduce the risk of anemia. This may involve:

• Identifying and avoiding trigger foods
• Incorporating nutrient-rich foods that are well-tolerated
• Ensuring adequate intake of iron, vitamin B12, and folic acid when possible

Surgical Interventions

For approximately 25-33% of UC patients who do not respond adequately to medical therapy, surgical options may be considered. Procedures such as colectomy can help manage severe UC and potentially reduce the risk of anemia-related complications.

How does proper UC management contribute to anemia prevention? By reducing intestinal inflammation and minimizing blood loss, effective UC management can help maintain proper nutrient absorption and prevent the development or worsening of anemia.

Monitoring and Follow-up: Ensuring Long-term Anemia Management in UC

Ongoing monitoring and regular follow-up are essential for managing anemia in UC patients. This involves:

• Regular blood tests to assess hemoglobin levels and iron status
• Periodic evaluations of UC disease activity
• Adjustments to treatment plans as needed
• Monitoring for potential side effects of anemia treatments

Patients should be vigilant about potential symptoms indicating changes in their condition and promptly report them to their healthcare provider. Signs that may warrant immediate medical attention include:

• Unexplained weight loss
• Significant loss of appetite
• Frequent, watery diarrhea
• Presence of blood, mucus, or pus in stools
• Persistent abdominal pain
• Increased fatigue or weakness

How often should UC patients undergo anemia screening? The frequency of anemia screening for UC patients depends on individual factors such as disease severity and previous history of anemia. Generally, healthcare providers recommend regular blood tests every 3-6 months, or more frequently during active disease phases.

Emerging Research: New Horizons in UC-related Anemia Management

Ongoing research in the field of UC-related anemia is paving the way for improved diagnostic tools and treatment strategies. Some areas of current investigation include:

Novel Iron Formulations

Researchers are exploring new iron formulations that may be better tolerated and more effectively absorbed by UC patients. These include:

• Nanoparticle-based iron supplements
• Heme iron polypeptides
• Iron-containing phosphates

Targeted Therapies

Emerging targeted therapies aim to address specific mechanisms of anemia in UC patients:

• Hepcidin antagonists to improve iron absorption
• Erythropoiesis-stimulating agents to boost red blood cell production
• Anti-inflammatory agents that specifically target anemia-related pathways

Microbiome Modulation

Research is underway to understand how the gut microbiome influences iron absorption and anemia in UC patients. This could lead to probiotic or prebiotic interventions to improve iron uptake and reduce anemia risk.

What potential impact could these emerging therapies have on UC-related anemia management? These innovative approaches could potentially offer more personalized and effective treatments for anemia in UC patients, leading to improved outcomes and quality of life. However, further research and clinical trials are necessary to establish their safety and efficacy.

Patient Education and Self-Management: Empowering UC Patients in Anemia Prevention

Educating UC patients about the link between their condition and anemia is crucial for effective self-management and prevention. Key aspects of patient education include:

Understanding Anemia Risk

Patients should be aware of their increased risk of developing anemia and the importance of regular monitoring. This knowledge can motivate them to adhere to treatment plans and attend follow-up appointments.

Recognizing Symptoms

Teaching patients to identify potential symptoms of anemia enables them to seek timely medical attention. This includes understanding both common and less frequent signs of anemia.

Dietary Considerations

While diet alone may not prevent or treat anemia in UC, patients should be educated about iron-rich foods and those that may enhance or inhibit iron absorption. This knowledge can help them make informed dietary choices when their condition is in remission.

Medication Adherence

Emphasizing the importance of adhering to prescribed UC medications can help prevent flare-ups and reduce the risk of anemia-related complications.

Stress Management

Teaching stress-reduction techniques can help patients manage UC symptoms and potentially reduce the risk of flare-ups that could lead to anemia.

How can healthcare providers effectively communicate the importance of anemia prevention to UC patients? Utilizing a combination of verbal explanations, written materials, and visual aids can help convey complex information about UC-related anemia. Additionally, encouraging patients to ask questions and express concerns can foster a collaborative approach to anemia prevention and management.

In conclusion, understanding the intricate relationship between ulcerative colitis and anemia is crucial for both healthcare providers and patients. By recognizing the increased risk of anemia in UC, implementing appropriate diagnostic and treatment strategies, and focusing on comprehensive disease management, it is possible to minimize the impact of anemia on individuals living with ulcerative colitis. Ongoing research and patient education continue to play vital roles in improving outcomes and quality of life for those affected by this challenging combination of conditions.

Ulcerative colitis and anemia: What is the link?

People living with ulcerative colitis (UC) are at an increased risk of developing anemia. Anemia can be serious, but is treatable.

UC is a form of inflammatory bowel disease that causes inflammation in the large intestine.

People with UC are at risk of developing anemia, a condition in which there are lower levels of red blood cells and the protein hemoglobin in the blood. This can be due to problems caused by UC, including reduced iron absorption, reduced absorption of other vitamins and minerals, and blood loss.

Learn more about the link between UC and anemia, including symptoms, treatment options, and long-term outlook.

People with UC are at risk of developing anemia. Roughly 1 in 3 people who live with UC also have anemia.

In UC and Crohn’s disease, another form of inflammatory bowel disease, inflammation in the intestine can prevent the body from absorbing iron properly. This can cause low iron levels, leading to anemia.

Intestinal bleeding may also result in blood loss, causing anemia. Anemia in people with UC could result from reduced absorption of vitamins and minerals, including vitamin B1 and folic acid. Some UC medications may also cause anemia.

Not everyone with anemia will experience symptoms, so it is important those with UC get a test for anemia.

If a person does experience symptoms of anemia, these may include:

• headaches
• lack of appetite
• difficulty with concentration or cognitive function
• irritability
• fatigue
• tingling in the hands or feet
• numbness in the hands or feet
• cold hands and feet

If anemia gets worse, more symptoms may develop. These include:

• abnormal menstrual bleeding
• ulcers in the mouth
• blue-ish color in the whites of the eyes
• brittle nails
• lightheadedness
• low libido in males
• inflamed or sore tongue
• shortness of breath

Doctors can diagnose anemia through a blood test to see if there are low levels of red blood cells and hemoglobin.

To diagnose anemia, a doctor may recommend tests for:

• complete blood count
• vitamin B12 levels
• iron levels
• folic acid levels
• reticulocyte count, the amount of immature red blood cells in the blood

A doctor may also do a physical exam to check for:

• rapid heart rate
• pale skin
• slight fever
• heart murmur
• low pressure, particularly upon standing

While anemia can be serious, it is also treatable.

Treatment options for anemia in people will UC will depend on the cause of the anemia and whether the UC is active.

A doctor will decide what treatment option is best, taking into account:

• whether UC is active
• whether other medical problems are present
• whether other nutritional deficiencies are present

Iron supplements

Iron supplements are one option for treating anemia in people with UC.

People who have UC in remission can take iron supplements orally. If someone with UC is in remission and can tolerate foods with iron, doctors recommend they begin to incorporate those foods into their diet.

If a person has UC that is not in remission, they may need to receive iron via an infusion with an IV line. This may also be the best option for those who cannot tolerate oral iron supplements.

Other medications

A doctor may prescribe other supplements to counteract the reduced absorption of certain vitamins and minerals due to UC.

Supplements may include vitamin B12 and folic acid.

Blood transfusion

In some cases, doctors may use a blood transfusion to treat severe anemia.

Before a blood transfusion, a healthcare professional will test a person’s blood to identify their blood type.

They will then insert an IV line into a blood vessel to deliver healthy blood. Typically, a blood transfusion will take 1–4 hours to complete.

A blood transfusion helps increase the hemoglobin and oxygen levels in the blood.

Managing UC to treat anemia

Getting UC under control through appropriate treatment may help treat anemia. There is no cure for UC, but a multifaceted approach to treatment can help manage the disease.

Treatment options for UC may include:

• Medications: Possible medications include aminosalicylates, corticosteroids, immunomodulators, targeted synthetic small molecules, and biologics. Medication can help limit flare-ups and reduce inflammation.
• Diet: Working with a doctor or dietitian to avoid foods that aggravate the digestive system may improve symptoms.
• Surgery: Between 25–33% of people with UC do not benefit from medical therapy. For these people, doctors may recommend a surgery such as a colectomy.

If a person is experiencing symptoms of anemia or unusual blood loss, they should call a doctor.

It is important for those living with UC to be aware of symptoms that may indicate a flare-up or worsening of the condition.

Symptoms that may indicate a change in a person’s condition and require a call to the doctor may include:

• weight loss
• loss of appetite
• frequent, watery diarrhea
• diarrhea that contains blood, mucus, or pus
• pain in the abdomen
• a sense of urgency to have a bowel movement
• fatigue

Any sudden or severe symptom requires attention from a doctor. In some cases, certain symptoms may warrant an emergency call to the doctor or a trip to the emergency room.

These symptoms include:

• new rectal bleeding
• significant amounts of rectal bleeding
• a drastic change in bowel movements without passing gas
• persistent vomiting and no bowel movements
• severe abdominal pain that persists for more than an hour
• a high temperature

Those with ulcerative colitis (UC) are at risk of developing anemia due to reduced iron absorption and potential blood loss. Certain medications and reduced absorption of minerals may also play a role in those with UC developing anemia.

Not everyone with anemia will experience symptoms, and it is important those with UC get a blood test to check if they have anemia.

While anemia can be serious, it is treatable. Treating anemia may involve taking oral iron or intravenous supplements. Managing UC will also help in the treatment of anemia.

ANEMIA | Crohn’s & Colitis Foundation

Modified: February 3, 2020

Dear @[email protected],

Your healthcare team has discussed the following subject with you: anemia. Here is some additional information. Let us know if you have any questions regarding this information.

People with Crohn’s disease or ulcerative colitis are at risk for anemia. If you have anemia, you have less blood to carry oxygen to the rest of your body. Approximately one in three people with Crohn’s disease or ulcerative colitis have anemia. The most common symptom is feeling tired. Other symptoms can include dizziness, headaches, cold hands or feet, pale skin, and shortness of breath.

The most common cause of anemia is low iron. With inflammatory bowel disease (IBD), long-term irritation and swelling (inflammation) in your intestines can interfere with your body’s ability to use and absorb iron properly. Other causes include slow blood loss from intestinal bleeding, poor absorption of vitamins and minerals (like vitamin B12 and folic acid), or from medications.

Not everyone experiences symptoms, so it is important that you get tested with a simple blood test to find out if you may have anemia. Iron deficiency, or low iron levels, can be serious, but treatable. Individuals with Crohn’s disease or ulcerative colitis that are in remission (or those without symptoms and without inflammation of the intestine) can take oral iron supplements. If you have Crohn’s disease or ulcerative colitis that is not in remission, or you cannot tolerate oral iron, then you may need intravenous (IV) iron. Other important factors in treatment include whether your IBD is under control, if you have other nutritional needs or deficiencies, and other medical problems you may have. You can discuss what options are best for you with your healthcare team and come to a mutual agreement.

Please be sure to follow up with your provider with any questions.

Your provider can also discuss the Crohn’s & Colitis Foundation’s IBD Anemia Care Pathway with you at your visit. The pathway uses guideline recommendations to identify and manage anemia. This resource is supported by Luitpold Pharmaceuticals

For further information, please check out https://www.crohnscolitisfoundation.org/diet-and-nutrition/supplementation or follow this link:

/sites/default/files/2020-03/anemia.pdf

Copy as URL

Copy as Word Doc

Copy as PDF

How to Copy Content for your EMR Tool »

Your Internet Explorer is outdated. For optimal security settings and a better experience on our site, try switching to one of these options:

Google Chrome

Download Chrome

Firefox

Download Firefox

Safari (macOS 10. 8+ only)

Download Safari

Diagnosis of ulcerative colitis – Health Clinic 365 Yekaterinburg

Your doctor will most likely be able to diagnose ulcerative colitis only after ruling out other diseases that cause similar symptoms, including Crohn’s disease, ischemic colitis, irritable bowel syndrome ( IBS), diverticulitis, and colon cancer. To confirm or refute the diagnosis of non-specific ulcerative colitis, you will have to undergo several tests:

Blood tests . Your doctor may suggest doing a complete blood count to look for anemia (a condition in which there are not enough red blood cells, the cells that carry oxygen to tissues) or to check for signs of infection. Test; looking for β-antineutrophil cytoplasmic antibodies can sometimes help determine what type of inflammatory bowel disease you have. But not all people with Crohn’s disease or ulcerative colitis have elevated levels of these antibodies.

Ulcerative colitis may present with the following non-specific symptoms:

Fecal analysis . The presence of white blood cells in the stool indicates the presence of inflammatory bowel disease, possibly ulcerative colitis. Calprotectin is a protein produced in leukocytes, its concentration in feces is directly proportional to the number of leukocytes in the intestine. Thus, determining the amount of calprotectin in feces is a study that allows diagnosing inflammatory bowel diseases. A stool test will also help rule out other causes of bowel problems, such as bacteria, viruses, and parasites. Your doctor may also order a stool culture to rule out bacteria in the gut that are often found in people with ulcerative colitis.

Colonoscopy . Colonoscopy is a diagnostic study that allows the doctor to examine the colonic mucosa using a thin, flexible, illuminated tube with a built-in video camera. During the procedure, the doctor may also remove small pieces of tissue (biopsy) for examination under a microscope to help confirm the diagnosis.

Sigmoidoscopy . During sigmoidoscopy, the doctor examines the sigmoid colon (the last section of the colon) using a special rectoscope device.

Colon x-ray with contrast . This study is usually performed in cases where a colonoscopy is not possible. Before an x-ray examination, the patient is given an enema with a contrast agent containing barium. Sometimes, air is also introduced into the intestine. Barium settles on the walls of the intestines, creating a silhouette of the rectum and large intestine, its image can be seen on x-rays.

Plain abdominal x-ray . If the patient has symptoms suggestive of toxic megacolon or bowel perforation, x-rays may be indicated.

Computed tomography (CT) . In some cases, your doctor may order you to have a CT scan of your abdomen, a special x-ray that provides a more accurate image than regular x-rays.

Ulcerative colitis

Ulcerative colitis (UC) is a chronic relapsing inflammatory disease of the colon, characterized by the presence of ulcers on its mucous membrane. As a result, abdominal pain, diarrhea, false urge to empty the intestines may appear. It is also possible to develop life-threatening complications – intestinal bleeding and colorectal cancer.

The cause of UC is still not exactly known. It is assumed that the main role in the development of the disease is played by immune and genetic factors.

Ulcerative colitis most commonly affects people between 15 and 30 years of age. The disease proceeds in periods: there are exacerbations and remissions (weakening of the manifestations of the disease up to their complete disappearance), and remission can sometimes last for years.

Drugs that suppress the immune system are commonly used for treatment. However, in some cases, only surgical treatment is possible.

Synonyms Russian

Nonspecific ulcerative colitis, NUC.

Synonyms English

Ulcerative Colitis,Colitis ulcerosa, UC.

Symptoms

The most common symptoms of UC are:

• chronic diarrhea with blood in the stool, sometimes mucus,
• abdominal pain, possibly of a cramping nature,
• feeling of incomplete emptying of the bowels and false urge to empty,
• anal fissures,
• intestinal bleeding,
• general weakness and malaise,
• temperature increase,
• loss of appetite and body weight,
• anemia due to bleeding and malabsorption of iron.

A number of symptoms are due to immune disorders:

• joint pain,
• inflammation of the eyes,
• skin lesions in the form of red, bumpy, painful rashes,
• pain in the right hypochondrium as a result of involvement in the pathological process of the liver,
• discomfort and pain in the lumbar region, indicating damage to the kidneys or the presence of stones in them.

General information

Ulcerative colitis is a chronic disease characterized by a relapsing course and the presence of inflammation and ulcers on the colonic mucosa.

The cause of UC is currently unknown. It is assumed that mainly disorders in the immune system and burdened heredity contribute to the disease.

Normally, human cells of the immune system synthesize antibodies to protect the body from foreign influences.

Some people’s immune systems produce too many antibodies against their own mucosal cells. Thus, the pathological process acquires an autoimmune character. This explains the presence of systemic manifestations of the disease in patients: arthritis, conjunctivitis, chronic hepatitis, erythema nodosum (bump-like, painful formations on the skin). The drug therapy of UC is based on the same version, since all the drugs used suppress the immune system.

People with a family history of UC are more likely to develop the disease than people with an uncomplicated heredity.

Increase the risk of getting UC stressful effects and diet, as well as past intestinal infections.

Normally, water, trace elements, and bile acids are absorbed in the large intestine. In chronic inflammation, this process is disrupted, the mucous membrane becomes thinner and ulcers appear on it, which can bleed. The result is a constant irritation of the intestines, which provokes diarrhea and abdominal pain. In addition, given the decrease in appetite, all this reduces the intake of nutrients, so that their level in the blood decreases, which is manifested by anemia, osteoporosis, protein deficiency, lack of glucose in the blood, hypovitaminosis.

Metabolic disorders occurring in the body can lead to impaired kidney function and the formation of stones in them.

With this pathology, only the superficial sections of the colon mucosa are affected. The inflammatory process is continuous, that is, starting in the rectum, it captures all parts of its mucosa, leaving no healthy fragments. In the future, inflammation can also continuously spread to the overlying parts of the colon.

During the course of the disease, periods of exacerbation and remission are distinguished, which can last for months or even years. At the same time, such patients have a high probability of intestinal bleeding, colorectal cancer, intestinal perforation, toxic megacolon (cessation of intestinal motility and expansion of the intestine), which can seriously threaten their lives.

Who is at risk?

• Persons whose relatives had ulcerative colitis.
• Young people under 30.
• Quitting smoking – this can provoke an exacerbation of UC.
• Long-term users of painkillers (non-steroidal anti-inflammatory drugs): ibuprofen, naproxen, aspirin.
• Residents of metropolitan areas.

Diagnosis

• Immunological blood test reveals antibodies to the cytoplasm of own neutrophils, which confirms the autoimmune nature of the disease and is quite specific for ulcerative colitis. Under the action of such antibodies, neutrophils are destroyed, which contributes to inflammatory reactions.
• Complete blood count (without leukocyte formula and ESR). A decrease in hemoglobin indicates anemia; an increase in the level of leukocytes may indicate the addition of an infection.
• Blood chemistry – helps to identify malabsorption, in which the levels of total protein, glucose, cholesterol, electrolytes may be reduced. Changes in the concentration of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase indicate liver damage. The level of creatinine, urea can increase with kidney pathology.
• C-reactive protein, an increase in the level of which indicates the activity of the process.
• The fecal occult blood test allows you to determine the amount of blood in the stool that is not visible to the eye.
• Coprogram reflects the ability of the gastrointestinal tract to digest food.

Instrumental methods of examination are also used:

• sigmoidoscopy – examination of the rectum and sigmoid colon;
• irrigoscopy – X-ray examination with the introduction of barium into the colon, allows you to explore the relief of the mucosa;
• fibrocolonoscopy – examination of the colon with an endoscope, which allows you to see changes in the mucosa and take a biopsy from the affected areas;
• Ultrasound of the abdominal organs and kidneys allows you to assess the condition of the intestinal wall, as well as the liver, gallbladder, pancreas, to identify changes in the kidneys;
• a histological examination of a biopsy (a piece of the intestinal mucosa taken during endoscopic examination) usually allows you to finally determine the type of disease.